Sciety invests in life science and digital health companies with the potential to become market leaders and drive meaningful change. They focus on companies in the Nordic region and utilize a rigorous selection process grounded in deep industry expertise. Their investment engagement is long-term, emphasizing active ownership as a key to creating value for both the companies and the investors. Sciety aims to capitalize on the increasing demand for drugs, innovative medical technology, and digital solutions driven by factors such as an aging population, increasing lifestyle diseases, and more demanding healthcare consumers. They also note the opportunities stemming from the biotechnological revolution in areas such as precision medicine and genomics. Sciety Venture Partners brings together experienced investors, from private investment firms and family offices to specialised investment companies, with a strong track record. They actively co-invest with Nordic and European venture capital and corporate venture capital firms.
Preferred startup development maturity for initial funding deployment.
Life Science, Digital Health, Drugs, Medical Technology, Digital Solutions, Precision Medicine, Genomics
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...